Skip to content
lsd.com

Indication

Suicidality

3 registered trials testing Psilocybin, Ketamine for this indication, 1 recruiting now.

3
Registered trials
1
Recruiting
0
In Phase 3

Substances tested

Being studied with

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Suicidality trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 3 trials for Suicidality

TrialStatusPhaseSubstanceSites
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and SuicidalityNCT06706232 · The University of Texas Health Science Center, HoustonRecruitingPhase 2psilocybin1
Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic TherapiesNCT07745569 · University of New MexicoNot yet recruitingPhase 2psilocybin—
Neural Correlates of Ketamine's Anti-suicidal Effects in Bipolar DepressionNCT05177146 · Centre for Addiction and Mental HealthCompletedNot applicableketamine1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.